Kinetics of Circulating Human Papillomavirus (cHPV) DNA in Plasma and Oral Gargles From Patients with HPV-Positive Oropharyngeal Cancer (OPC) Treated with Definitive Radiation TherapyMichelle Echevarria, J.J. Caudell, Christine H. Chung et al.|International Journal of Radiation Oncology*Biology*Physics|2022Cited by 2
Proliferation Saturation Index to Simulate Adaptive Radiation Fractionation in HPV-Associated Oropharyngeal CancerMohammad U. Zahid, Heiko Enderling, G.Q. Yang et al.|International Journal of Radiation Oncology*Biology*Physics|2023Cited by 2
Phase I Dose Escalation/Dose Expansion Trial of NBTXR3/SBRT in Combination with Nivolumab or Pembrolizumab for the Treatment of Anti-PD-1 Naïve or Resistant Patients with Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaC. Shen, J.J. Caudell, Po‐Cheng Chang et al.|International Journal of Radiation Oncology*Biology*Physics|2025Cited by 1
Utility of Intermediate Risk Volumes in Human Papilloma Associated Oropharyngeal Cancer: A Pattern of Failure AnalysisG.Q. Yang, J.J. Caudell, Michelle Echevarria|International Journal of Radiation Oncology*Biology*Physics|2022Cited by 1
MO-0871 HPV DNA in plasma and oral gargle from patients with HPV oropharyngeal cancer treated with radiationMichelle Echevarria, Christine H. Chung, J.J. Caudell et al.|Radiotherapy and Oncology|2023Cited by 0